# Analysis of Machine Learning Algorithms for Alzheimer's Disease Prediction Based on Clinical Data

## 1.0 INTRODUCTION

Alzheimer's disease is a profound and complex neurodegenerative disorder that has gained increasing attention in the fields of medicine, neuroscience, and public health. Reports of the incidence and mortality of AD in the USA presented it as the seventh leading cause of death, with an incidence of about 6.5 million and a projected 13.8 million by 2060 (Gaugler et al., 2022). Likewise, the 2016 World Alzheimer's Report projected that from 2016 to 2050, there would be an increase from 46.8 million to 131 million in the incidence of AD across the globe (Albrecht et al., 2021). Characterized by progressive cognitive decline, memory loss, and a range of behavioral and psychological symptoms, Alzheimer's disease is a major contributor to the global burden of dementia. As the leading cause of dementia, this devastating condition impacts not only the lives of millions of individuals but also their families and caregivers. Given the growing prevalence of Alzheimer's disease, there is a critical need to deepen our understanding of its underlying mechanisms, risk factors, and potential therapeutic interventions. This research paper provides an in-depth exploration of Alzheimer's disease, its pathophysiology, clinical manifestations, and current state of research, to contribute to the ongoing efforts aimed at better understanding, diagnosing, and treating this profound ailment.

Machine learning has emerged as an indispensable tool in the field of bioinformatics, and is currently being applied in six key subfields of bioinformatics such as microarrays, evolution, systems biology, genomics, text mining, and proteomics (Aditya & Sanjay, 2020). Bioinformatics, the intersection of biology and data science, relies on machine learning algorithms to make sense of genetic sequences, predict protein structures, and elucidate complex biological processes. With the ever-increasing availability of biological data, machine learning has become an essential component in identifying genetic markers for diseases, drug discovery, and understanding intricate biological pathways. Machine learning algorithms are generally divided into weak classifier algorithms and strong classifier algorithms. For example, logistic regression (LR), support vector machine (SVM), and artificial neural network (ANN) are weak classifier algorithms, and random forests (RF) and extreme gradient enhancement (XGBoost) are strong classifier algorithms. A strong classifier can be composed of more than one weak classifier (Zhihang et al., 2022). This introduction sets the stage for the pivotal role that machine learning plays in the advancement of bioinformatics, offering insights into how it enables the transformation of biological data into meaningful knowledge, ultimately driving innovations in healthcare, genetics, and personalized medicine.

## 1.1 PROBLEM BACKGROUND

Diagnosing Alzheimer's disease remains a challenging endeavor, primarily reliant on a combination of clinical evaluation, cognitive assessments, and neuroimaging techniques. Lack of knowledge on precise molecular changes is one significant factor making the development of effective AD treatments difficult (Alzheimer’s Association, 2020). While these methods have significantly improved our ability to identify the disease, they are not without their limitations. The possibility of preventing the development of Alzheimer’s disease (AD) also receiving increasing attention, particularly due to the limited availability of effective disease-modifying treatments (DMTs) (Crous Bou M et al., 2017). The gold standard for definitive Alzheimer's diagnosis still involves post-mortem neuropathological examination, making clinical diagnosis less than ideal. Moreover, Alzheimer's disease shares symptoms with other forms of dementia, leading to misdiagnosis and delayed treatment initiation. This diagnostic uncertainty not only hampers the provision of timely care but also complicates research into potential treatments and interventions. Thus, the need for more accurate, objective, and early diagnostic approaches is evident.

Recent advances in machine learning have opened new avenues for the prediction of Alzheimer's disease. Machine learning algorithms, trained on diverse datasets, have shown promise in identifying patterns, risk factors, and biomarkers associated with the disease.  These algorithms can analyze a range of data sources, including medical history, genetics, cognitive assessments, and neuroimaging data, to offer more accurate and timely predictions. Meanwhile, with the rapid development of artificial intelligence (AI), machine learning algorithm, as an important branch, has been widely used in the diagnostic classification and prognostic prediction of diseases (Zhihang et al., 2022). By extracting meaningful information from this wealth of information, machine learning models have the potential to provide personalized risk assessments and early detection. However, while this field is promising, it is also evolving rapidly, with various methods and models being explored, and their clinical adoption still requires rigorous validation and fine-tuning to ensure their accuracy and reliability. Thus, the research on the use of machine learning in Alzheimer's prediction is a dynamic and evolving domain, presenting both opportunities and challenges in the quest for improved diagnosis and understanding of this devastating disease.

## 1.2 PROBLEM STATEMENT

The current issue centers around the imperative need for more precise and reliable predictive models to enhance our ability to predict and manage Alzheimer's disease. Traditional diagnostic methods, often relying primarily on clinical assessments, may not harness the full potential of the available data. We need a more effective and accurate approach that considers a broad spectrum of data sources, irrespective of specific disease stages or individual features.

To address this issue, we propose the development of a machine learning-based predictive model using machine learning methods. This model aims to utilize a wide range of available data sources, including demographic information and relevant clinical and neuroimaging measurements, to provide a more accurate early diagnosis and better understanding of Alzheimer's disease progression.

## 1.3 OBJECTIVES

The objectives of the research are :
1. To study Alzheimer's disease and the algorithm performance in diagnosing and classifying Alzheimer’s disease.
2. To predict Alzheimer’s disease using machine learning approaches: Support Vector Machine (SVM),  Random Forest, Decision Tree, and ElasticNet to classify Alzheimer’s disease with feature selection.
3. To evaluate the result from all machine learning algorithms with p-values feature selection in terms of accuracy, sensitivity, and specificity in the classification of Alzheimer’s disease. 

## 1.4 SCOPES

The scope of the research is as follows:
- This research is focused on predicting the infectious state of Alzheimer’s disease which affects patients.
- The dataset used in this research focuses only on the clinical report of Alzheimer’s disease acquired from the Open Access Series of Imaging Studies (OASIS).
- The measurement of performance is based on classification accuracy and algorithm efficiency.
- The programming language used to run this algorithm in this research is Python.

## 1.5 CONCLUSION

Machine learning offers promise for improving Alzheimer's disease prediction by identifying patterns and biomarkers. However, clinical application requires rigorous validation. Our research is dedicated to addressing diagnostic challenges and developing a validated model to enhance Alzheimer's disease diagnosis. With a focus on Alzheimer's disease and machine learning, our study aspires to predict and assess the condition. By leveraging data-driven methods, we aim to improve Alzheimer's disease diagnostics, ultimately leading to improved patient care and a better grasp of this challenging ailment. This research sets the stage for a future in which precise diagnoses and early interventions become the standard of care.

## REFERENCES

1. Hwang, U., Kim, S. W., Jung, D., Kim, S., Lee, H., Seo, S. W., Seong, J., & Yoon, S. (2023). Real-world prediction of Preclinical Alzheimer’s disease with a deep generative model. *Artificial Intelligence in Medicine*, 144, 102654. [Read more](https://doi.org/10.1016/j.artmed.2023.102654)

2. Pu, Y., Beck, D., & Verspoor, K. (2023). Graph embedding-based link prediction for literature-based discovery in Alzheimer’s Disease. *Journal of Biomedical Informatics*, 145, 104464. [Read more](https://doi.org/10.1016/j.jbi.2023.104464)

3. MRI and Alzheimers. (2017, August 16). Kaggle. [Dataset](https://www.kaggle.com/datasets/jboysen/mri-and-alzheimers?select=oasis_longitudinal.csv)

4. Jiang, Z., Shao, M., Dai, X., Pan, Z., & Li, D. (2022). Identification of diagnostic biomarkers in systemic lupus erythematosus based on bioinformatics analysis and machine learning. *Frontiers in Genetics*, 13. [Read more](https://doi.org/10.3389/fgene.2022.865559)

5. Tanveer, M., Richhariya, B., Khan, R. U., Rashid, A. H., Khanna, P., Prasad, M., & Lin, C. (2020). Machine learning techniques for the diagnosis of Alzheimer’s disease. *ACM Transactions on Multimedia Computing, Communications, and Applications*, 16(1s), 1–35. [Read more](https://doi.org/10.1145/3344998)

6. Stevenson-Hoare, J., Schalkamp, A., Sandor, C., Hardy, J., & Escott‐Price, V. (2023). New cases of dementia are rising in elderly populations in Wales, UK. *Journal of the Neurological Sciences*, 451, 120715. [Read more](https://doi.org/10.1016/j.jns.2023.120715)

7. Kavitha, C., Mani, V., Srividhya, S., Khalaf, O. I., & Romero, C. a. T. (2022). Early-Stage Alzheimer’s disease prediction using machine learning models. *Frontiers in Public Health*, 10. [Read more](https://doi.org/10.3389/fpubh.2022.853294)
